FIELD: pharmacology.
SUBSTANCE: group of inventions is designed to prevent exacerbation, as well to treat gastroesophageal reflux disease. 4-[({6-[isobutyl(1,3-thiazol-2-ylsulfonyl)amino]-2,3-dihydro-1H-inden-5-yl}oxy)methyl]-3-methylbenzoic acid, its salt or a prodrug thereof is used.
EFFECT: increased effectiveness of gastroesophageal reflux disease prevention and treatment.
10 cl, 3 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING GASTROESOPHAGEAL REFLUX DISEASE CASES | 2002 |
|
RU2280443C2 |
| METHOD FOR REPAIRING ANTIREFLUX FUNCTION LOWER ESOPHAGEAL SPHINCTER | 2005 |
|
RU2277946C1 |
| DEVICE FOR INJECTION THERAPY OF GASTROESOPHAGEAL REFLUX DISEASE | 2011 |
|
RU2514093C2 |
| THERAPEUTIC AGENT IN DISTURBED URINATION | 2008 |
|
RU2452479C2 |
| METHOD FOR DIAGNOSING HIGH GASTROESOPHAGEAL REFLUXES | 2017 |
|
RU2659955C1 |
| METHOD OF TREATMENT OF LARYNGOPATHY CAUSED BY GASTROESOPHAGEAL REFLUX | 2007 |
|
RU2346711C1 |
| SULFONAMIDE COMPOUNDS AND SALTS THEREOF | 2009 |
|
RU2481329C2 |
| METHOD OF TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE | 2007 |
|
RU2338559C1 |
| ANTAGONISTS OF METBOTROPIC GLUTAMATE RECEPTOR 5 (MGLUR5) AND METHODS OF PREVENTION AND TREATMENT OF GASTROESOPHAGEAL REFLUX (OPTIONS) | 2003 |
|
RU2324484C2 |
| COMBINED APPLICATION OF PROSTAGLANDIN DERIVATIVE AND PROTON PUMP INHIBITOR FOR TREATMENT OF GASTROINTESTINAL DISEASES | 2006 |
|
RU2468800C2 |
